78 filings
Page 2 of 4
8-K
2vhlze5
13 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
n26 rlyqfz5
16 Jun 16
Termination of a Material Definitive Agreement
12:00am
8-K
vd9jv9e3xz2z4 u5krr1
14 Jun 16
Other Events
12:00am
8-K
gr3j slj290
27 May 16
Changes in Registrant's Certifying Accountant
12:00am
8-K
cxqff v4axta06ssuaa0
26 May 16
Acucela Announces Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat
12:00am
8-K
xoyrbbghlpqmbwrolyw
26 May 16
Other Events
12:00am
8-K
7kbnn9tnkgjh4slsun
6 May 16
Results of Operations and Financial Condition
12:00am
8-K
1ckd91d
28 Apr 16
Other Events
12:00am
8-K
qt1xfz
5 Apr 16
Acucela Licenses Gene Therapy from The University of Manchester for Retinal Degenerative Disease
12:00am
8-K
0vauww28gi9mm
31 Mar 16
Other Events
12:00am
8-K
zp4lg4 8ds1g
29 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
elgk snkcflde
17 Mar 16
Acucela Secures Option to Exclusively License Novel Cataract Treatment
12:00am
8-K
k099 cuxm8
9 Mar 16
Results of Operations and Financial Condition
12:00am
8-K
gw4pgqf4lq0et m6orcs
16 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
lqb5dod0f 0lz
15 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
p1oyoyx76usk17 7v3eu
27 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
l6vi10p9q6
24 Nov 15
Departure of Directors or Certain Officers
12:00am
8-K
ihl2n d106
20 Nov 15
Regulation FD Disclosure
12:00am
8-K
9ixzy855js zh
12 Nov 15
Results of Operations and Financial Condition
12:00am
8-K
jni 6d29aw7qz
5 Aug 15
Revisions to Earnings Forecasts
12:00am